Flash
Why Food Safety Officers Are Checking Fake PaneerIndia Wins Gold Medal in Shooting at Asian GamesIndia Plans to Run Many Hydrogen Buses by 2030Election Commission Should Check Party MoneyIndian Athletes Win Medals at Asian GamesTiruppur Clothes Export Crosses Big MilestoneActivists Threaten Protests If Election Chief Does Not QuitIndian Stock Market Falls Sharply As Oil Prices Go UpWhy Food Safety Officers Are Checking Fake PaneerIndia Wins Gold Medal in Shooting at Asian GamesIndia Plans to Run Many Hydrogen Buses by 2030Election Commission Should Check Party MoneyIndian Athletes Win Medals at Asian GamesTiruppur Clothes Export Crosses Big MilestoneActivists Threaten Protests If Election Chief Does Not QuitIndian Stock Market Falls Sharply As Oil Prices Go Up
PulseGridNews & Live Broadcast
AllPoliticsBusinessTechnologySportsEntertainmentWorld
PulseGrid

Automated, always-on coverage of AI, tech and markets.

Categories

  • Politics
  • Business
  • Technology
  • Sports
  • Entertainment
  • World

Company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms of Service
  • RSS Feed
  • Sitemap

© 2026 PulseGrid News. All rights reserved.

Region:All RegionsIndiaGlobal
All CategoriesPoliticsBusinessTechnologySportsEntertainmentWorldLive TV
Business

US Drug Agency Clears Indian Pharma Plant

Aurobindo Pharma got good news from the United States food and drug agency for its factory in North Carolina.

Published Aug 18
US Drug Agency Clears Indian Pharma Plant

What happened

A medicine factory in North Carolina owned by Aurobindo Pharma received a positive update from the United States Food and Drug Administration. The agency checked the factory and gave it a status called Voluntary Action Indicated. This means the plant meets good standards after some minor fixes.

Why it matters

  • The company can now sell new medicines from this factory.
  • Pending drug requests can move forward for approval.
  • It helps the business grow and make more money in America.

What happens next

The company will keep working with health officials to make safe medicines. Patients can expect new inhalers and other treatments to move through the review process much faster now.